The largest database of trusted experimental protocols

17 protocols using pspax2

1

Lentiviral Transduction of FGFR1 and GFP

Check if the same lab product or an alternative is used in the 5 most similar protocols
FGFR1 and GFP expressing lentiviruses were generated by co-transfecting 4 μg proviral pLX302-FGFR1 or pLX302-GFP plasmids (Open BioSystems), 3 μg psPAX2 (plasmid encoding gag, pol, rev, and Tat genes) and 1 μg pMDG2 envelope plasmid (Sigma Aldrich) into 293FT cells using Lipofectamine 2000 (Thermo Fisher). 293FT cells were fed with growth media 24 h post-transfection; virus-containing supernatants were harvested 48 and 72 h post-transfection, diluted 1:4 and applied to target cells with 8 μg/mL polybrene (Sigma Aldrich). Target cells were selected with 1 μg/mL puromycin.
+ Open protocol
+ Expand
2

siRNA and shRNA Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For siRNA treatment cells (3 × 106) were electroporated without or with 200 nM non-targeting or specific siRNA (Dharmacon, Inc.) as described previously12 (link).
For shRNA, lentivirus was produced by combining MISSION constructs for packaging (psPAX2), envelope (pDM2G) and targeting shRNA or a non-targeting vector (pLKO.1), at a 4:2:1 ratio (Sigma Aldrich, St. Louis, MO). Polyethylenimine (PEI; Polysciences) was combined with DNA at a 3:1 ratio, and added to 70% confluent HEK 293LTV cells. Conditioned media was collected 24 and 48 hrs post transfection by centrifugation, and viral supernatant added to cells with 8 μg/ml hexadimethrine bromide (polybrene, Sigma-Aldrich). Gene expression was measured by QPCR 24 hrs following puromycin selection (2 μg/ml).
+ Open protocol
+ Expand
3

Lentiviral Vector Production and Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
All plasmids were purified utilizing a GenElute HP Plasmid Midiprep Kit (Sigma) after transformation using DH5α cells with ampicillin. Lentiviral packing plasmids, pMD2.G and psPAX2, were purchased from Sigma. LentiCRISPRv2 was obtained as a gift from Dr. Anil Rustgi (Columbia University, New York, NY, USA). The single-guide RNA (sgRNA) sequence targeting the MEN1 gene (Supplemental Table S1) was cloned into the lentiCRISPRv2 vector as previously described [6 (link)]. shRNA plasmids for LXRα were obtained from the University of Pennsylvania Perelman School of Medicine High-Throughput Screening Core (Philadelphia, PA, USA), all of which were derived from a pLKO.1-puromycin backbone, with sequences for the LXRα shRNAs listed in Supplemental Table S1. The pLKO-Tet-On was obtained from Addgene and used to generate doxycycline-inducible menin shRNAs using two validated menin shRNA sequences (Supplemental Table S1) as previously described [23 (link),24 (link)]. To produce lentivirus, 293T cells were transfected with pMD2.G, psPAX2, and the plasmid of interest using Fugene 6 (Promega, Madison, WI, USA) according to the manufacturer’s instructions. After collecting and filtering the virus, cells were then transduced in the presence of 4 μg/mL polybrene (hexadimethrine bromide). Twenty-four hours after completion of transduction, cells were then selected with puromycin for 72 h.
+ Open protocol
+ Expand
4

Generation and Transduction of FGFR1 Lentivirus

Check if the same lab product or an alternative is used in the 5 most similar protocols
T47D and CAMA-1 cells were obtained from ATCC and were cultured in DMEM supplemented with 10% fetal bovine serum (FBS). FGFR1− and GFP-expressing lentiviruses were generated by co-transfecting 4-mg proviral pLX302-FGFR1 or pLX302-GFP plasmids (Open BioSystems), 3 mg psPAX2 (plasmid encoding gag, pol, rev, and Tat genes), and 1 mg pMDG2 envelope plasmid (Sigma Aldrich) into 293FT cells using Lipofectamine 2000 (Thermo Fisher). 293FT cells were fed with 10% DMEM-FBS 24 h after transfection; virus-containing supernatants were harvested 48 and 72 h after transfection, diluted 1:4 and applied to target cells with 8 mg/mL polybrene (Sigma Aldrich). Target cells were selected with 1 mg/mL puromycin.
+ Open protocol
+ Expand
5

Lentiviral Transduction of Prmt5 Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral packing plasmids pMD2.G and psPAX2 were purchased from Sigma-Aldrich (St. Louis, USA). shRNA plasmids for Prmt5 was pLKO.1-puromycin backbone-based and obtained from the University of Pennsylvania Perelman School of Medicine High-Throughput Screening Core. To produce lentivirus, as previously reported (Matkar et al. 2015 (link)), 293T cells were transfected with pMD2.G, psPAX2, and the plasmid of Prmt5 shRNA using Fugene 6 (Promega, Madison, USA) according to the manufacturer’s instructions. For all virus production, after collecting and filtering the virus, cells were then transduced. Twenty four hours after completion of transduction, cells were then selected with puromycin for 72 hours.
+ Open protocol
+ Expand
6

Stable Modulation of FOXA1 and HIF1A in PCa

Check if the same lab product or an alternative is used in the 5 most similar protocols
FOXA1 stable KD pGIPZ lentiviral shRNA construct (Clone ID #V2LHS_16780) was obtained from Open Biosystems (Pittsburg, PA, USA). HIF1A stable KD PLKO lentiviral shRNA was purchased from Sigma-Aldrich. For FOXA1 OE construct, FOXA1 was first cloned into pCR8 Gateway compatible entry vector, then transferred into pLenti-HA-Flag gateway compatible destination vector by LR recombination. For incorporation of FOXA1-shRNA, HIF1A-shRNA, FOXA1-OE, and empty vector control lentiviral plasmids into PCa cells, lentiviruses carrying the constructs were made. To produce lentivirus from lentiviral vectors, HEK293T cells were transfected with a mixture of our transfer plasmids, psPAX2 (virus packaging plasmid), and pMD2G (envelope plasmid) by the PEI transfection method (Sigma). Culture medium containing virus was collected 48h after transfection and filtered through a 0.45 μm filter to remove cell debris or cells. The collected lentiviruses were added to the target cells in the presence of polybrene (8 μg/ml) to incubate for 6–8 h. 24h after infection, cells were selected with 1μg/ml puromycin.
+ Open protocol
+ Expand
7

Lentiviral Transduction in HEK293FT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral expression vectors were co-transfected into HEK293FT cells with the lentiviral packaging plasmids psPAX2 and pMD2.G (#12260 and #12259; Addgene). In brief, 3 × 106 HEK293FT cells were seeded into a poly-L-lysine-coated 10-cm culture dish the day before transfection. For each 10-cm dish, the following DNA was diluted in 0.6 ml of OptiMEM (Thermo Fisher Scientific): 4.5 μg of lentiviral vector, 6 μg of psPAX2 and 1.5 μg of pMD2.G. Separately, 35 μL of 1 μg/μL 25 kDa polyethylenimine (PEI; Sigma) was diluted into 600 µL of OptiMEM, briefly vortexed and incubated at room temperature for 5 min. After incubation, the DNA and PEI mixtures were combined, briefly vortexed and incubated at room temperature for 20 min. During this incubation, the culture medium was replaced with 8 ml of pre-warmed DMEM + 1% FBS. The transfection mixture was then added dropwise to the 10-cm dish. Viral particles were collected 48 h after the medium change and filtered through a 0.45-μm PVDF syringe filter. The filtered supernatant was used directly to infect cells. Aliquots were snap-frozen and stored at −80 °C. For transduction, lentiviral particles were diluted in complete growth medium supplemented with 10 μg/ml polybrene (Sigma) and added to cells.
+ Open protocol
+ Expand
8

Lentiviral Transduction and CRISPR Knockout

Check if the same lab product or an alternative is used in the 5 most similar protocols
A lentiviral packing system including plasmids pMD2.G and psPAX2 (Sigma) was utilized to knock down gene expression via delivering shRNA into the target cells. All lentiviral shRNA plasmids were derived from a pLKO.1‐puromycin backbone. shRNA plasmids of JunD, Pbk, and scramble shRNA were obtained from the University of Pennsylvania Perelman School of Medicine High‐Throughput Screening Core. Specific shRNA sequences can be found in Appendix Table S3.
LentiCRISPRv2 was obtained as a gift from Dr. Anil Rustgi for use to knock out genes via a CRISPR technique. The lentiCRISPRv2 vector with Men1 targeted sgRNA was sequenced to confirm that the correct insert was in place. Specific sgRNA sequences are in Appendix Table S3. To produce lentivirus, HEK293T cells were transfected with pMD2.G, psPAX2, and the sgRNA expression plasmid of interest using the calcium chloride precipitation method as previously reported (Katona et al,2019).
A pMX‐puro‐Pbk construct, as previously published, and a mutant plasmids with K64K65 to AA based on pMX‐puro‐Pbk construct, were transfected into INS‐1 cell line to induce ectopic expression of Pbk.
Cells were transduced by the virus of choice in the presence of 4 μg/ml polybrene (hexadimethrine bromide) for lentivirus infection. 24 h after completion of transduction, cells were then selected with puromycin for 72 h.
+ Open protocol
+ Expand
9

Lentiviral Knockdown Approach in A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
pLKO lentiviral vectors for gene knockdown and the pLKO-scrambled (Scr) short hairpin (sh)RNA vector (control) were obtained from Sigma-Aldrich; Merck KGaA. The shRNA sequences for the pLKO lentiviral vector constructions are listed in Table II. A total of 6×106 293T cells were seeded into 100-mm cell culture dishes and incubated at 37°C and 5% CO2 for 16 h. When the cultured cells reached 85% confluence, cells were co-transfected with 3 µg of lentiviral expression constructs pLKO.1-shRNA, pMD2.G and psPAX2 (Sigma- Aldrich; Merck KGaA) using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocol. Viral supernatants were collected by centrifugation at 800 × g for 5 min at 25°C and filtered through a 0.22-µm membrane filter 48 h post-transfection and stored at −80°C. A549 cells (5×106 cells per 100-mm culture dish) were seeded and incubated overnight at 37°C prior to infection. Medium was then replaced with 1:1 diluted viral supernatant supplemented with 8 µg/ml polybrene and incubated for 24 h at 37°C, followed by replacement with normal growth medium. Stable cell lines with shRNA were selected by puromycin (Clontech Laboratories, Inc.) at a final concentration of 2 µg/ml in A549 cells.
+ Open protocol
+ Expand
10

Generating PTPRD Knockdown Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
PTPRD shRNA (bacterial glycerol stocks of five different sequences) and the non-targeting scrambled shRNA, pLKO.1-puro, were purchased from Sigma Aldrich. Each DNA sample (2 μg) was co-treated with psPAX2 (Sigma Aldrich, 1.5 μg), pMD2.G (Sigma Aldrich, 0.5 μg), and E-fection (2 μg/μg DNA) for lentiviral production in 293TN cells. Viruses were harvested at 24 and 48 h. Lentiviral constructs and 8 μg/mL polybrene (Chemicon, Billerica, MA, USA) were used to transfect MKN74 cells, which were then selected with puromycin (1 μg/mL), to generate stable cell lines. The efficiency of PTPRD mRNA knockdown by the five different shRNA sequences was tested by qRT-PCR and shPTPRD #3 was chosen for subsequent experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!